Skip to content
AiViva BioPharma
Menu
Home
AiViva BioPharma
Menu
Home
Uncategorized
Sorry, we couldn't find any posts. Please try a different search.
Search
Recent Posts
AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
December 11, 2023
AiViva BioPharma Appoints Les Kaplan, PhD, to the Board of Directors
December 7, 2023
AiViva BioPharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors
August 30, 2023
AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema
May 22, 2023
AiViva BioPharma Announces New Patent Received
August 17, 2022
Categories
Investor & Media
(1)
News
(1)
Press Releases
(7)
Archives
December 2023
August 2023
May 2023
August 2022
May 2022
October 2020
June 2020
Scroll To Top